Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Mar 15;346(Pt 3):785–791.

Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.

D R Brown 1
PMCID: PMC1220913  PMID: 10698707

Abstract

The inherited prion diseases such as Gerstmann-Sträussler-Scheinker syndrome (GSS) are linked to point mutations in the gene coding for the cellular isoform of the prion protein (PrP(C)). One particular point mutation A117V (Ala(117)-->Val) is linked to a variable pathology that usually includes deposition of neurofibrillary tangles. A prion protein peptide carrying this point mutation [PrP106-126(117V)] was generated and compared with a peptide based on the normal human sequence [PrP106-126(117A)]. The inclusion of this point mutation increased the toxicity of PrP106-126 which could be linked to an increased beta-sheet content. An assay of microtubule formation in the presence of tau indicated that PrP106-126 decreased the rate of microtubule formation that could be related to the displacement of tau. PrP106-126 carrying the 117 mutation was more efficient at inhibiting microtubule formation. These results suggest a possible mechanism of toxicity for protein carrying this mutation via destabilization of the cytoskeleton and deposition of tau in filaments, as observed in GSS.

Full Text

The Full Text of this article is available as a PDF (220.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown D. R., Besinger A. Prion protein expression and superoxide dismutase activity. Biochem J. 1998 Sep 1;334(Pt 2):423–429. doi: 10.1042/bj3340423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown D. R., Herms J. W., Schmidt B., Kretzschmar H. A. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells. Eur J Neurosci. 1997 Jun;9(6):1162–1169. doi: 10.1111/j.1460-9568.1997.tb01470.x. [DOI] [PubMed] [Google Scholar]
  3. Brown D. R., Herms J., Kretzschmar H. A. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport. 1994 Oct 27;5(16):2057–2060. doi: 10.1097/00001756-199410270-00017. [DOI] [PubMed] [Google Scholar]
  4. Brown D. R., Mohn C. M. Astrocytic glutamate uptake and prion protein expression. Glia. 1999 Feb 1;25(3):282–292. doi: 10.1002/(sici)1098-1136(19990201)25:3<282::aid-glia8>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  5. Brown D. R. Prion protein peptide neurotoxicity can be mediated by astrocytes. J Neurochem. 1999 Sep;73(3):1105–1113. doi: 10.1046/j.1471-4159.1999.0731105.x. [DOI] [PubMed] [Google Scholar]
  6. Brown D. R., Schmidt B., Kretzschmar H. A. A neurotoxic prion protein fragment enhances proliferation of microglia but not astrocytes in culture. Glia. 1996 Sep;18(1):59–67. doi: 10.1002/(SICI)1098-1136(199609)18:1<59::AID-GLIA6>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  7. Brown D. R., Schmidt B., Kretzschmar H. A. Prion protein fragment interacts with PrP-deficient cells. J Neurosci Res. 1998 May 1;52(3):260–267. doi: 10.1002/(SICI)1097-4547(19980501)52:3<260::AID-JNR2>3.0.CO;2-B. [DOI] [PubMed] [Google Scholar]
  8. Brown D. R., Schmidt B., Kretzschmar H. A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 1996 Mar 28;380(6572):345–347. doi: 10.1038/380345a0. [DOI] [PubMed] [Google Scholar]
  9. Brown D. R., Schulz-Schaeffer W. J., Schmidt B., Kretzschmar H. A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol. 1997 Jul;146(1):104–112. doi: 10.1006/exnr.1997.6505. [DOI] [PubMed] [Google Scholar]
  10. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H. P., DeArmond S. J., Prusiner S. B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992 Apr 16;356(6370):577–582. doi: 10.1038/356577a0. [DOI] [PubMed] [Google Scholar]
  11. Davis A., Sage C. R., Wilson L., Farrell K. W. Purification and biochemical characterization of tubulin from the budding yeast Saccharomyces cerevisiae. Biochemistry. 1993 Aug 31;32(34):8823–8835. doi: 10.1021/bi00085a013. [DOI] [PubMed] [Google Scholar]
  12. Florio T., Grimaldi M., Scorziello A., Salmona M., Bugiani O., Tagliavini F., Forloni G., Schettini G. Intracellular calcium rise through L-type calcium channels, as molecular mechanism for prion protein fragment 106-126-induced astroglial proliferation. Biochem Biophys Res Commun. 1996 Nov 12;228(2):397–405. doi: 10.1006/bbrc.1996.1673. [DOI] [PubMed] [Google Scholar]
  13. Ghetti B., Dlouhy S. R., Giaccone G., Bugiani O., Frangione B., Farlow M. R., Tagliavini F. Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol. 1995 Jan;5(1):61–75. doi: 10.1111/j.1750-3639.1995.tb00578.x. [DOI] [PubMed] [Google Scholar]
  14. Ghetti B., Piccardo P., Frangione B., Bugiani O., Giaccone G., Young K., Prelli F., Farlow M. R., Dlouhy S. R., Tagliavini F. Prion protein amyloidosis. Brain Pathol. 1996 Apr;6(2):127–145. doi: 10.1111/j.1750-3639.1996.tb00796.x. [DOI] [PubMed] [Google Scholar]
  15. Ghetti B., Piccardo P., Spillantini M. G., Ichimiya Y., Porro M., Perini F., Kitamoto T., Tateishi J., Seiler C., Frangione B. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):744–748. doi: 10.1073/pnas.93.2.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Giese A., Brown D. R., Groschup M. H., Feldmann C., Haist I., Kretzschmar H. A. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 1998 Jul;8(3):449–457. doi: 10.1111/j.1750-3639.1998.tb00167.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harris D. A., Falls D. L., Johnson F. A., Fischbach G. D. A prion-like protein from chicken brain copurifies with an acetylcholine receptor-inducing activity. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7664–7668. doi: 10.1073/pnas.88.17.7664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hsiao K. K., Cass C., Schellenberg G. D., Bird T., Devine-Gage E., Wisniewski H., Prusiner S. B. A prion protein variant in a family with the telencephalic form of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 1991 May;41(5):681–684. doi: 10.1212/wnl.41.5.681. [DOI] [PubMed] [Google Scholar]
  19. Hsiao K., Prusiner S. B. Inherited human prion diseases. Neurology. 1990 Dec;40(12):1820–1827. doi: 10.1212/wnl.40.12.1820. [DOI] [PubMed] [Google Scholar]
  20. Johnson B. D., Byerly L. A cytoskeletal mechanism for Ca2+ channel metabolic dependence and inactivation by intracellular Ca2+. Neuron. 1993 May;10(5):797–804. doi: 10.1016/0896-6273(93)90196-x. [DOI] [PubMed] [Google Scholar]
  21. Kretzschmar H. A. Human prion diseases (spongiform encephalopathies). Arch Virol Suppl. 1993;7:261–293. doi: 10.1007/978-3-7091-9300-6_21. [DOI] [PubMed] [Google Scholar]
  22. Mastrianni J. A., Curtis M. T., Oberholtzer J. C., Da Costa M. M., DeArmond S., Prusiner S. B., Garbern J. Y. Prion disease (PrP-A117V) presenting with ataxia instead of dementia. Neurology. 1995 Nov;45(11):2042–2050. doi: 10.1212/wnl.45.11.2042. [DOI] [PubMed] [Google Scholar]
  23. Prusiner S. B., Hsiao K. K. Human prion diseases. Ann Neurol. 1994 Apr;35(4):385–395. doi: 10.1002/ana.410350404. [DOI] [PubMed] [Google Scholar]
  24. Prusiner S. B. Molecular biology of prion diseases. Science. 1991 Jun 14;252(5012):1515–1522. doi: 10.1126/science.1675487. [DOI] [PubMed] [Google Scholar]
  25. Schätzl H. M., Da Costa M., Taylor L., Cohen F. E., Prusiner S. B. Prion protein gene variation among primates. J Mol Biol. 1995 Jan 27;245(4):362–374. doi: 10.1006/jmbi.1994.0030. [DOI] [PubMed] [Google Scholar]
  26. Tagliavini F., Giaccone G., Prelli F., Verga L., Porro M., Trojanowski J. Q., Farlow M. R., Frangione B., Ghetti B., Bugiani O. A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Brain Res. 1993 Jul 9;616(1-2):325–329. doi: 10.1016/0006-8993(93)90226-d. [DOI] [PubMed] [Google Scholar]
  27. Tateishi J., Kitamoto T., Doh-ura K., Sakaki Y., Steinmetz G., Tranchant C., Warter J. M., Heldt N. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome. Neurology. 1990 Oct;40(10):1578–1581. doi: 10.1212/wnl.40.10.1578. [DOI] [PubMed] [Google Scholar]
  28. Tranchant C., Sergeant N., Wattez A., Mohr M., Warter J. M., Delacourte A. Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation. J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):240–246. doi: 10.1136/jnnp.63.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Whatley S. A., Powell J. F., Politopoulou G., Campbell I. C., Brammer M. J., Percy N. S. Regulation of intracellular free calcium levels by the cellular prion protein. Neuroreport. 1995 Nov 27;6(17):2333–2337. doi: 10.1097/00001756-199511270-00015. [DOI] [PubMed] [Google Scholar]
  30. Yoshida H., Ihara Y. Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau. J Neurochem. 1993 Sep;61(3):1183–1186. doi: 10.1111/j.1471-4159.1993.tb03642.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES